Convergence Insufficiency Treatment Trial - Attention and Reading Trial

Information

  • Research Project
  • 9269195
  • ApplicationId
    9269195
  • Core Project Number
    U10EY022587
  • Full Project Number
    5U10EY022587-04
  • Serial Number
    022587
  • FOA Number
    PAR-10-207
  • Sub Project Id
  • Project Start Date
    5/1/2014 - 10 years ago
  • Project End Date
    4/30/2019 - 5 years ago
  • Program Officer Name
    REDFORD, MARYANN
  • Budget Start Date
    5/1/2017 - 7 years ago
  • Budget End Date
    4/30/2018 - 6 years ago
  • Fiscal Year
    2017
  • Support Year
    04
  • Suffix
  • Award Notice Date
    6/8/2017 - 7 years ago
Organizations

Convergence Insufficiency Treatment Trial - Attention and Reading Trial

DESCRIPTION (provided by applicant): This proposal is for the Pennsylvania College of Optometry at Salus University to serve as a clinical center for the Convergence Insufficiency Treatment Trial - Attention and Reading Trial (CITT-ART), a multicenter, randomized, placebo controlled, clinical trial designed to evaluate the effects of treatment for symptomatic convergence insufficiency (Cl) on measures of reading performance and attention in children. In this trial, 324 children aged 9 to <14 years with symptomatic Cl will be randomly assigned to 16 weeks of: 1) office-based vergence/ accommodative therapy with home-reinforcement or 2) office-based placebo therapy. After 16 weeks of treatment, the primary outcome measures of reading comprehension (Wechsler Individual Achievement test [WIAT-III] reading comprehension subtest score) and attention (Strengths and Weaknesses of ADHD Symptoms & Normal Behavior Scale [SWAN]) will be assessed by examiners masked to treatment group. The Gates MacGinitie-4 test, which uses a format similar to curriculum-based evaluation done in classrooms, will provide a secondary measure of reading comprehension. Reading fluency, another test of attention, the Cl Symptom Survey, and clinical measures of Cl (i.e., the near point of convergence, and positive fusional vergence at near) are other secondary outcome measures; also included are assessments of key reading and cognitive components that impact reading comprehension including pseudoword decoding, word reading, and listening comprehension. Long-term effects on reading achievement and attention are assessed 1-year post treatment. This application documents our site's ability to recruit at least 36 subjects and o retain them for 1 year after completion of treatment. Documentation is provided that our site has the appropriate personnel, equipment, and facilities to conduct the study in accordance with the CITT-ART Manual of Procedures (MOP). Complete details of the study rationale, design, and methods are contained in the Manual of Procedures (submitted with the Study Chair and Data Coordinating Center [DCC] applications). In addition to our center, there are 8 other optometric or ophthalmologic centers, the Study Chair at the Pennsylvania College of Optometry at Salus University, and the DCC at The Ohio State University Optometry Coordinating Center. Symptomatic Cl is a common vision disorder in children that is commonly associated with symptoms while reading (e.g. loss of place, loss of concentration, frequent re-reading, reading slowly, trouble remembering what was read). However, the effect of Cl treatment on reading and attention is unknown. The results of the proposed study will lead to a better understanding of these relationships and have important implications for educators, psychologists, and physicians who care for children with reading and attention problems. The findings will guide hypothesis development for future scientific investigations in children with vision disorders.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    U10
  • Administering IC
    EY
  • Application Type
    5
  • Direct Cost Amount
    41245
  • Indirect Cost Amount
    17323
  • Total Cost
    58568
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    867
  • Ed Inst. Type
    SCHOOLS OF OPTOMETRY/OPHT TECH
  • Funding ICs
    NEI:58568\
  • Funding Mechanism
    OTHER RESEARCH-RELATED
  • Study Section
    ZEY1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SALUS UNIVERSITY
  • Organization Department
    PEDIATRICS
  • Organization DUNS
    077069904
  • Organization City
    ELKINS PARK
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    190271576
  • Organization District
    UNITED STATES